Exploring procedure duration and risk for serious adverse events during congenital cardiac catheterization

被引:3
|
作者
Yeh, Mary J. [1 ]
Lydon, Elizabeth [2 ]
Gauvreau, Kimberlee [1 ]
Jenkins, Kathy J. [1 ]
Slater, David [2 ]
Bergersen, Lisa [1 ]
机构
[1] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA
[2] MITRE Corp, McLean, VA USA
关键词
Cardiac Devices; Methodology; Patient Outcome Assessment; Outcomes Research; HEART-DISEASE; COMPLICATIONS;
D O I
10.1136/bmjsit-2022-000142
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives While procedure length is considered an important metric for cardiothoracic surgical procedures, the relationship between procedure length and adverse events (AEs) in congenital cardiac catheterizations has little published data available. Furthermore, most existing congenital cardiac catheterization risk prediction models are built on logistic regression models. This study aimed to characterize the relationship between case length and AE occurrence in congenital cardiac catheterization while adjusting for known risk factors and to investigate the potential role of non-linear analysis in risk modeling.Design Age, case type, and procedure duration were evaluated for relationships with the primary outcome using logistic regression. Non-linearity of the associations with continuous risk factors was assessed using restricted cubic spline transformations.Setting and participants All diagnostic and interventional congenital cardiac catheterization cases performed at Boston Children's Hospital between January 1, 2014 and October 31, 2019 were analyzed.Main outcome measure The primary outcome was defined as the occurrence of any clinically significant (level 3/4/5) AE.Results A total of 7011 catheterization cases met inclusion criteria, with interventional procedures accounting for 68% of cases. Median case duration was 97 min. A multivariable model including age, procedure type, and case duration showed a significant relationship between case duration and AE occurrence (OR 1.07 per 10 min increase, 95% CI 1.06 to 1.09, p<0.001).Conclusions This study demonstrated the importance of procedure duration as a potential frontier for procedure risk management. Better understanding of the role of procedure duration in cardiac catheterizations may provide opportunities for quality improvement in patient safety and resource planning.
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Impact of Dosing and Duration of Dexamethasone on Serious Corticosteroid-Related Adverse Events
    An, Amy W.
    Chen, Xi
    Urbauer, Diana L.
    Bruera, Eduardo
    Hui, David
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2024, 67 (01) : 59 - 68
  • [32] Meningococcal Vaccination and Risk of Serious Adverse Events A Systematic Review
    Fernanda Fontalvo-Mendoza, Maria
    Marcela Perez-Romero, Diana
    Quintana-Pajaro, Loraine
    Carlos Ramos-Villegas, Yan
    Garcia Ballestas, Ezequiel
    Florez-Perdomo, William A.
    Ghosh, Amrita
    Pal, Ranabir
    Rafael Moscote-Salazar, Luis
    Agrawal, Amit
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2022, 30 (02) : 1 - 6
  • [33] Reevaluating the Risk of Serious Adverse Events of Carbonic Anhydrase Inhibitors
    Bleicher, Isaac D.
    Rossin, Elizabeth J.
    Vavvas, Demetrios G.
    JAMA OPHTHALMOLOGY, 2022, 140 (07) : 745 - 746
  • [34] Rates of serious adverse events in patients on high risk medications
    Metlay, Joshua P.
    Hennessy, Sean
    Localio, Russell
    Leonard, Charles E.
    Tjia, Jennifer
    Cohen, Abigail
    Haynes, Kevin
    Yang, Wei
    Han, Xiaoyan
    Kimmel, Stephen E.
    Feldman, Harold I.
    Strom, Brian L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S102 - S102
  • [35] Cardiac and vascular serious adverse events following tixagevimab- cilgavimab
    Piszczek, Jolanta
    Murthy, Srinivas
    Afra, Kevin
    LANCET RESPIRATORY MEDICINE, 2023, 11 (01): : E5 - E6
  • [36] Risk factors for adverse cardiac events in adults with fulminant myocarditis during hospitalization
    Tie-Duo Kang
    Yan-Long Ren
    Han Zhao
    Shang-Qiu Ning
    Wen-Xian Liu
    World Journal of Clinical Cases, 2020, (02) : 255 - 263
  • [37] Renovascular disease and the risk of adverse cardiac events
    Edwards, MS
    Craven, TE
    Burke, GL
    Dean, RH
    Hansen, KJ
    CIRCULATION, 2003, 108 (17) : 633 - 634
  • [38] Risk factors for adverse cardiac events in adults with fulminant myocarditis during hospitalization
    Kang, Tie-Duo
    Ren, Yan-Long
    Zhao, Han
    Ning, Shang-Qiu
    Liu, Wen-Xian
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (02) : 255 - 263
  • [39] Intracoronary stenting and risk for major adverse cardiac events during the first month
    Schühlen, H
    Kastrati, A
    Dirschinger, J
    Hausleiter, J
    Elezi, S
    Wehinger, A
    Pache, J
    Hadamitzky, M
    Schömig, A
    CIRCULATION, 1998, 98 (02) : 104 - 111
  • [40] Adverse Event Rates in Congenital Cardiac Catheterization - A Multi-Center Experience
    Bergersen, Lisa
    Marshall, Audrey
    Gauvreau, Kimberlee
    Beekman, Robert
    Hirsch, Russel
    Foerster, Susan
    Balzer, David
    Vincent, Julie
    Hellenbrand, William
    Holzer, Ralf
    Cheatham, John
    Moore, John
    Lock, James
    Jenkins, Kathy
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2010, 75 (03) : 389 - 400